Semler Scientific (FRA:6FA) ROCE % : 37.31% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Semler Scientific ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Semler Scientific's annualized ROCE % for the quarter that ended in Mar. 2024 was 37.31%.

Semler Scientific ROCE % Historical Data

The historical data trend for Semler Scientific's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Semler Scientific ROCE % Chart

Semler Scientific Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

124.59

71.82

52.72

34.84

35.55

Semler Scientific Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															42.49	45.07	40.79	14.73	37.31

Semler Scientific ROCE % Calculation

Semler Scientific's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	21.082	/	( ( (59.182 - 6.473)	+	(71.586 - 5.685) )	/ 2 )
	=	21.082	/	( (52.709	+	65.901)	/ 2 )
	=	21.082	/	59.305
	=	35.55 %

Semler Scientific's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	25.672	/	( ( (71.586 - 5.685)	+	(77.148 - 5.431) )	/ 2 )
	=	25.672	/	( ( 65.901	+	71.717 )	/ 2 )
	=	25.672	/	68.809
	=	37.31 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Semler Scientific (FRA:6FA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Semler Scientific ROCE % Related Terms

Thank you for viewing the detailed overview of Semler Scientific's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Semler Scientific (FRA:6FA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Semler Scientific Inc (FRA:6FA) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

SMLR:USA 6FA:Germany

Address

2340-2348 Walsh Avenue, Suite 2344, Santa Clara, CA, USA, 95051

Website

http://www.semlerscientific.com

Semler Scientific Inc is a US-based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.

Semler Scientific (FRA:6FA) Headlines

No Headlines